- Report
- November 2023
- 94 Pages
United States
From €5390EUR$5,950USD£4,646GBP
- Report
- June 2023
- 183 Pages
Global
From €2491EUR$2,750USD£2,147GBP
€4982EUR$5,500USD£4,295GBP
- Report
- April 2024
- 185 Pages
Global
From €4077EUR$4,500USD£3,514GBP
- Report
- July 2024
- 120 Pages
Global
From €4303EUR$4,750USD£3,709GBP
- Report
- October 2023
- 102 Pages
Global
From €4031EUR$4,450USD£3,475GBP
- Report
- October 2023
- 146 Pages
Global
From €3759EUR$4,150USD£3,240GBP
- Report
- December 2023
- 91 Pages
Global
From €3500EUR$4,139USD£3,122GBP
- Report
- October 2023
- 85 Pages
Global
From €3500EUR$4,139USD£3,122GBP
- Report
- September 2023
- 96 Pages
Global
From €3500EUR$4,139USD£3,122GBP
- Report
- May 2023
- 95 Pages
Global
From €3500EUR$4,139USD£3,122GBP
- Report
- March 2024
- 132 Pages
Global
From €861EUR$950USD£742GBP
- Book
- December 2024
- 256 Pages
Contrast media, also known as contrast agents, are substances used to enhance the visibility of structures or fluids within the body during medical imaging procedures. Microbubbles are a type of contrast media that are composed of a gas core surrounded by a shell of lipids or proteins. They are used in ultrasound imaging to improve the contrast between different tissues and organs. Microbubbles are also used in targeted drug delivery, as they can be loaded with drugs and targeted to specific areas of the body.
Microbubbles are a rapidly growing market within the contrast media industry. They are increasingly being used in a variety of medical imaging procedures, such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). Microbubbles are also being used in targeted drug delivery, as they can be loaded with drugs and targeted to specific areas of the body.
Some companies in the microbubbles market include Bracco Diagnostics, Guerbet, Lantheus Medical Imaging, and SonoVue. Show Less Read more